Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|September 17, 2004
Immune recovery of lymphocyte subsets 6 years after autologous peripheral blood stem cell transplantation (PBSCT) for lymphoproliferative diseases. A comparison between NHL, HD and MM in group of 149 patientsLuca Laurenti, Paola Piccioni, Nicola Piccirillo, et al.
Leukemia Research|October 1, 2010
Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive diseaseGiovanni D'Arena, Luca Laurenti, Maria Marta Minervini, et al.
American Journal of Hematology|May 31, 2007
Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemiaGiovanni D'Arena, Michela Tarnani, Carlo Rumi, et al.
Leukemia Research|January 22, 2008
Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndromeLuca Laurenti, Silvia De Matteis, Mario Sabatelli, et al.
Cancers|December 9, 2023
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center ExperienceIdanna Innocenti, Alberto Fresa, Annamaria Tomasso, et al.
European Journal of Haematology|September 18, 2010
Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patientsGiovanni D'Arena, Silvana Capalbo, Luca Laurenti, et al.
Annals of Hematology|July 1, 2008
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response durationLuca Laurenti, Michela Tarnani, Laura De Padua, et al.
Leukemia & Lymphoma|August 9, 2023
Pulmonary infections in patients with acute myeloid leukemia receiving frontline treatment with hypomethylating agentsMaria Cristina Scamuffa, Roberto Latagliata, Ida Carmosino, et al.
Annals of Hematology|July 14, 2010
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcomeLuca Laurenti, Laura De Padua, Michela Tarnani, et al.
American Journal of Hematology|July 11, 2006
Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemiaGiovanni D'Arena, Luca Laurenti, Silvana Capalbo, et al.
Pageof 3